Concepedia
Statistics
Publications
49
Citations
5.4K
H-Index
33
Active since
1969
Affiliations
Beth Israel Deaconess Medical Center(Current)
Beth Israel Deaconess Hospital
Harvard University
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Mark A. Peppercorn is an author at Beth Israel Deaconess Medical Center specializing in medicine, gastroenterology, and pathology.
Top concepts
MedicineGastroenterologyPathologyInflammationImmunologySurgeryAutoimmune DiseaseGastrointestinal PathologyPharmacologyChronic Inflammatory Diseases
Publications per year
1969–2011
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
Richard J. Farrell, Mazen Alsahli, Yoon‐Tae Jeen et al. · Gastroenterology · 2003 · 557 citations
Inflammation, Anti-inflammatory, Autoimmune Disease +6
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
Alain Bitton, Mark A. Peppercorn, Donald A. Antonioli et al. · Gastroenterology · 2001 · 479 citations
Inflammation, Chronic Inflammatory Diseases, Mucosal Immunology +8
Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
Stephen B. Hanauer, Burton I. Korelitz, Paul Rutgeerts et al. · Gastroenterology · 2004 · 466 citations
Gastroenterology, Disease Remission, Postoperative Treatment +6
THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE
Mark A. Peppercorn, Peter Goldman · Journal of Pharmacology and Experimental Therapeutics · 1972 · 435 citations
Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
John W. Singleton, Stephen B. Hanauer, Gary Gitnick et al. · Gastroenterology · 1993 · 359 citations
Anti-inflammatory, Mesalamine Capsules, Pharmacology +5
1–5 of 49